These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 13811110)

  • 21. On the changes of plasmin activity caused by radiation treatment in cancer patients and effects of antiplasmin (ipsilon) administration.
    YAMASHITA H; IGARI S; TANAKA T
    Keio J Med; 1961 Dec; 10():195-207. PubMed ID: 14008905
    [No Abstract]   [Full Text] [Related]  

  • 22. AN ACTIVE STEREO-ISOMER (TRANS-FORM) OF AMCHA AND ITS ANTIFIBRINOLYTIC (ANTIPLASMINIC) ACTION IN VITRO AND IN VIVO.
    OKAMOTO S; SATO S; TAKADA Y; OKAMOTO U
    Keio J Med; 1964 Dec; 13():177-85. PubMed ID: 14279228
    [No Abstract]   [Full Text] [Related]  

  • 23. Presence in bovine milk of two protease inhibitors of the plasmin system.
    Precetti AS; Oria MP; Nielsen SS
    J Dairy Sci; 1997 Aug; 80(8):1490-6. PubMed ID: 9276788
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [ON THE ORIGIN OF ATONIC HEMORRHAGE AND AFIBRINOGENEMIA, AND ANTIPLASMIN AND ANTITRYPSIN BLOOD DISEASES].
    MAKI M
    Nihon Sanka Fujinka Gakkai Zasshi; 1963 Nov; 15():1207-10. PubMed ID: 14096727
    [No Abstract]   [Full Text] [Related]  

  • 25. Studies of the plasmin system. III. Physical properties of the two plasmin inhibitors in plasma.
    NORMAN PS; HILL BM
    J Exp Med; 1958 Nov; 108(5):639-49. PubMed ID: 13587848
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Determination of antiplasmin activity of urine].
    Obodchuk GS; Byshevskiĭ ASh
    Lab Delo; 1976; (1):50-1. PubMed ID: 56493
    [No Abstract]   [Full Text] [Related]  

  • 27. Role of proteinase/antiproteinase inhibitor disequilibrium in the bioincompatibility induced by artificial surfaces.
    Deppisch R; Haug U; Göhl H; Ritz E
    Nephrol Dial Transplant; 1994; 9 Suppl 3():17-23. PubMed ID: 7521027
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasminogen-plasmin system. VII. Potentiation of antifibrinolytic action of a synthetic inhibitor, tranexamic acid, by alpha 2-macroglobulin antiplasmin.
    Abiko Y; Iwamoto M
    Biochim Biophys Acta; 1970 Sep; 214(3):411-8. PubMed ID: 4251764
    [No Abstract]   [Full Text] [Related]  

  • 29. [alpha 2-Plasmin inhibitor-plasmin complex (PIC)].
    Yoshikawa Y; Sakata Y
    Nihon Rinsho; 1995 Mar; 53 Su Pt 2():55-8. PubMed ID: 8753179
    [No Abstract]   [Full Text] [Related]  

  • 30. [t-PA-PAI-1 complex].
    Maruyama I
    Nihon Rinsho; 1999 Sep; 57 Suppl():688-90. PubMed ID: 10543214
    [No Abstract]   [Full Text] [Related]  

  • 31. [The significance of measurement of alpha 2PI-plasmin complex in acute promyelocytic leukemia].
    Asakura H; Itoh K; Johkaji Y; Saito M; Uotani C; Kumabashiri I; Matsuda T
    Rinsho Ketsueki; 1988 Apr; 29(4):534-8. PubMed ID: 2969985
    [No Abstract]   [Full Text] [Related]  

  • 32. Fibrinolysin and antifibrinolysin; biochemical concentration of antifibrinolysin.
    LOOMIS EC; RYDER A; GEORGE C
    Arch Biochem; 1949 Feb; 20(2):444-50. PubMed ID: 18108935
    [No Abstract]   [Full Text] [Related]  

  • 33. [Influence of antiplasmin on fibrinolysis and fibrinogenolysis].
    Bratus' GM; Byshevskiĭ ASh
    Ukr Biokhim Zh; 1971; 43(2):178-82. PubMed ID: 4254692
    [No Abstract]   [Full Text] [Related]  

  • 34. [Recent progress on analysis of blood coagulation factors and fibrinolytic agents; alpha 2 plasmin inhibitor plasmin complex].
    Itoh N
    Rinsho Byori; 1989 Apr; Spec No 81():202-7. PubMed ID: 2526884
    [No Abstract]   [Full Text] [Related]  

  • 35. Like fibrin, (DD)E, the major degradation product of crosslinked fibrin, protects plasmin from inhibition by alpha2-antiplasmin.
    Lee AY; Fredenburgh JC; Stewart RJ; Rischke JA; Weitz JI
    Thromb Haemost; 2001 Mar; 85(3):502-8. PubMed ID: 11307822
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Molecular markers of hemostatic-mechanisms--plasmin-alpha 2 plasmin inhibitor complex].
    Kawai Y; Watanabe K
    Rinsho Byori; 1989 Mar; 37(3):248-55. PubMed ID: 2526263
    [No Abstract]   [Full Text] [Related]  

  • 37. Platelet antiplasmin: its extrusion during the release reaction, subcellular localization, characterization, and relationship to antiheparin in pig platelets.
    Joist JH; Niewiarowski S; Nath N; Mustard JF
    J Lab Clin Med; 1976 Apr; 87(4):659-69. PubMed ID: 131845
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [STUDIES ON TRYPSIN INHIBITOR AND ANTIPLASMIN IN HUMAN SERUM. II. ON VARIOUS DISEASES EXCEPT ARTERIOSCLEROSIS].
    MATSUDA T
    Nihon Ketsueki Gakkai Zasshi; 1963 Oct; 26():590-7. PubMed ID: 14098708
    [No Abstract]   [Full Text] [Related]  

  • 39. [Increased complexes between protease and protease inhibitor in the plasma from patients with neoplasm].
    Okadome T; Maruyama I; Shinmyouzu K; Jounosono M; Osame M
    Rinsho Ketsueki; 1988 Dec; 29(12):2283-6. PubMed ID: 2977624
    [No Abstract]   [Full Text] [Related]  

  • 40. An enzyme-linked immunosorbent assay (ELISA) for the measurement of plasmin-alpha 2-antiplasmin complex in human plasma--application to the detection of in vivo activation of the fibrinolytic system.
    Holvoet P; de Boer A; Verstreken M; Collen D
    Thromb Haemost; 1986 Oct; 56(2):124-7. PubMed ID: 2433784
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.